These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15497236)

  • 1. Review of "Implications of Hormesis for Industrial Hygiene".
    Brosseau LM
    Hum Exp Toxicol; 2002 Jul; 21(7):395. PubMed ID: 15497236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormesis and industrial hygiene: a new hypothesis for low-dose response in occupational risk assessment.
    Carelli G; Iavicoli I; Castellino N
    Hum Exp Toxicol; 2002 Jul; 21(7):401-3. PubMed ID: 15497240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comments on "Implications of Hormesis for Industrial Hygiene".
    Brown SL
    Hum Exp Toxicol; 2002 Jul; 21(7):397-8. PubMed ID: 15497238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implications of hormesis for industrial hygiene.
    Jayjock MA; Lewis PG
    Hum Exp Toxicol; 2002 Jul; 21(7):385-9. PubMed ID: 12269701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Jayjock and Lewis reply.
    Jayjock MA; Lewis PG
    Hum Exp Toxicol; 2002 Jul; 21(7):407-8. PubMed ID: 15497243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormesis: the new approach in risk assessment?
    Christiani DC; Zhou W
    Hum Exp Toxicol; 2002 Jul; 21(7):399-400. PubMed ID: 15497239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comments: implications of hormesis for industrial hygienists.
    Brophy MO
    Hum Exp Toxicol; 2002 Jul; 21(7):391-3. PubMed ID: 15497233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Special endpoint and product specific considerations in pharmaceutical acceptable daily exposure derivation.
    Gould J; Callis CM; Dolan DG; Stanard B; Weideman PA
    Regul Toxicol Pharmacol; 2016 Aug; 79 Suppl 1():S79-93. PubMed ID: 27233924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The marginalization of hormesis.
    Calabrese EJ; Baldwin LA
    Toxicol Pathol; 1999; 27(2):187-94. PubMed ID: 10207983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comments on the Jayjock et al. paper.
    Rozman KK
    Hum Exp Toxicol; 2002 Jul; 21(7):405-6. PubMed ID: 15497241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fundamental flaws of hormesis for public health decisions.
    Thayer KA; Melnick R; Burns K; Davis D; Huff J
    Environ Health Perspect; 2005 Oct; 113(10):1271-6. PubMed ID: 16203233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using default methodologies to derive an acceptable daily exposure (ADE).
    Faria EC; Bercu JP; Dolan DG; Morinello EJ; Pecquet AM; Seaman C; Sehner C; Weideman PA
    Regul Toxicol Pharmacol; 2016 Aug; 79 Suppl 1():S28-38. PubMed ID: 27233926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical hormesis: its historical foundations as a biological hypothesis.
    Calabrese EJ; Baldwin LA
    Toxicol Pathol; 1999; 27(2):195-216. PubMed ID: 10207984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harmonization efforts for deriving health-based exposure limits in the pharmaceutical industry - Advancing the current science and practice.
    Weideman PA; Pecquet AM; Maier MA
    Regul Toxicol Pharmacol; 2016 Aug; 79 Suppl 1():S1-2. PubMed ID: 27531049
    [No Abstract]   [Full Text] [Related]  

  • 15. Testing threshold and hormesis in a random effects dose-response model applied to developmental toxicity data.
    Hunt D; Rai SN
    Biom J; 2005 Jun; 47(3):319-28. PubMed ID: 16053256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic implications of hormesis.
    Hammitt JK
    Hum Exp Toxicol; 2004 Jun; 23(6):267-78; discussion 279-80, 303-5. PubMed ID: 15301153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic implications of hormesis in policy making.
    Griffiths C
    Hum Exp Toxicol; 2004 Jun; 23(6):281-3; discussion 303-5. PubMed ID: 15301154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Principles of risk assessment for determining the safety of chemicals: recent assessment of residual solvents in drugs and di(2-ethylhexyl) phthalate.
    Hasegawa R; Koizumi M; Hirose A
    Congenit Anom (Kyoto); 2004 Jun; 44(2):51-9. PubMed ID: 15198717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examining the risks and benefits of considering both the traditional dose--response and hormesis in arriving at an acceptable exposure level.
    Pickrell JA; Oehme FW
    Hum Exp Toxicol; 2006 Jan; 25(1):23-7. PubMed ID: 16459711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementing Toxicity Testing in the 21st Century (TT21C): Making safety decisions using toxicity pathways, and progress in a prototype risk assessment.
    Adeleye Y; Andersen M; Clewell R; Davies M; Dent M; Edwards S; Fowler P; Malcomber S; Nicol B; Scott A; Scott S; Sun B; Westmoreland C; White A; Zhang Q; Carmichael PL
    Toxicology; 2015 Jun; 332():102-11. PubMed ID: 24582757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.